Results 11 to 20 of about 155,017 (308)
Acute Myeloid Leukemia in Suspected Sepsis after Caesarean Section [PDF]
Korean Journal of Critical Care Medicine, 2014 The incidence of acute leukemia during pregnancy is extremely rare, and often it is not easy to differentiate it from other diseases associated with pregnancy such as sepsis or hemorrhage.
Myoung Hwa Kim +6 more
doaj +6 more sources
European Journal of Inflammation, 2007 The combination of acute leukemia and pregnancy is infrequent. It is estimated to occur in less than 1 in 75,000 pregnancies. Maternal and fetal outcomes have improved substantially in recent years.
V. Karagiannis +6 more
doaj +2 more sources
Clinicopathological evaluation of acute leukemias in a tertiary care hospital: a cross-sectional study [PDF]
Turkish Journal of Pathology, 2021 Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) are clinically and biologically diverse phenotypic diseases amongst hematological malignancies. The current study objectives were to diagnose and classify cases of AL as per revised 4th edition of WHO 2016 classification of AL's and study their clinicopathological profiles.This cross ...
Gayatri N. PATEL +4 more
openaire +4 more sources
Chronic Myeloid Leukemia and Cesarean Section: The Anesthesiologist’s Point of View [PDF]
Case Reports in Obstetrics and Gynecology, 2018 Background . Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm related to chromosomal reciprocal translocation t(9;22). Tyrosine kinase inhibitors (TKIs) such as imatinib have drastically revolutionized the course and the prognosis of this hematologic malignancy.
Houssam Rebahi +2 more
openaire +4 more sources
Haematologica, 2021 FMS-like Tyrosine Kinase 3 (FLT3) mutation is associated with poor survival in acute myeloid leukemia (AML). The specific Anexelekto/MER Tyrosine Kinase (AXL) inhibitor, ONO-7475, kills FLT3-mutant AML cells with targets including Extracellular- signal ...
Sean M. Post +16 more
doaj +1 more source
Iron oxide nanoparticles in leukemia: design, diagnostic applications, and therapeutic strategies
Journal of the Egyptian National Cancer InstituteLeukemia, a heterogeneous group of hematologic malignancies, poses significant challenges in terms of early diagnosis and effective treatment. Recent advancements in nanotechnology have paved the way for innovative approaches in leukemia management, with
Henry Fenekansi Kiwumulo +6 more
doaj +2 more sources
Haematologica, 2022 Strategies to overcome resistance to FMS-like tyrosine kinase 3 (FLT3)-targeted therapy in acute myeloid leukemia (AML) are urgently needed.
Weiguo Zhang +14 more
doaj +1 more source
Blood Cancer Journal, 2023 TP53-mutant acute myeloid leukemia (AML) respond poorly to currently available treatments, including venetoclax-based drug combinations and pose a major therapeutic challenge.
Bing Z. Carter +15 more
doaj +1 more source
PLATELET INDICES IN LEUKEMIAS: - A CROSS SECTIONAL STUDY
Journal of Medical Sciences, 2022 Objective: To evaluate the pattern of changes in the platelet indices in different Leukemias. Material and method: This descriptive cross-sectional study was conducted in the Pathology Department of Khyber Teaching Hospital from January 2021 to December 2021 (1-year duration).
Huma Riaz +5 more
openaire +1 more source
Paraffin Section Immunophenotyping of Acute Leukemias in Bone Marrow Specimens [PDF]
American Journal of Clinical Pathology, 1996 The immunohistochemical evaluation of acute leukemia specimens has been limited in the past due of the inability to detect many lineage-related antigens in paraffin sections. With the improvement in immunohistochemical methods as well as the introduction of new antibodies, these limitations are now reduced.
D A, Arber, K A, Jenkins
openaire +2 more sources